Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
Find generic entry opportunities
Manage your formulary budget
Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
|Abstract:||A new metered unit dose comprising 40 .mu.g or less of budesonide is disclosed as well as a formulation thereof and the use thereof for the treatment of conditions in the nose.|
|Inventor(s):||Nilsson; Hans (Lund, SE), Santesson; Gordon (Horby, SE)|
|Assignee:||Astra Aktiebolag (Sodertalje, SE)|
Patent Claim Types:|
see list of patent claims
Back Citations: 3rd percentile
Forward Citations: 1st percentile
|Patent Number||Expiration Date|
|6,686,346||February 03, 2012|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Sweden||9604486||Dec 05, 1996|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||1310243||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.